Serum LDH level is a prognostic factor in locoregionally advanced nasopharyngeal carcinoma (NPC) patients treated with chemoradiotherapy

被引：0
|
作者：
Turen, S
Ozyar, E
Altundag, K
Gullu, I
Atahan, IL
机构：
[1] Hacettepe Univ, Dept Radiat Oncol, Ankara, Turkey
[2] Hacettepe Univ, Dept Med Oncol, Ankara, Turkey
来源：
RADIOTHERAPY AND ONCOLOGY | 2004年 / 73卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S306 / S306
页数：1
相关论文
共 50 条
  • [1] Serum LDH level is a prognostic factor in locoregionally advanced nasopharyngeal carcinoma (NPC) patients treated with chemoradiotherapy
    Turen, S
    Ozyar, E
    Altundag, MK
    Gullu, I
    [J]. LUNG CANCER, 2004, 46 : S82 - S82
  • [2] Serum lactate dehydrogenase level is a prognostic factor in patients with locoregionally advanced nasopharyngeal carcinoma treated with chemoradiotherapy
    Turen, Selahattin
    Ozyar, Enis
    Altundag, Kadri
    Gullu, Ibrahim
    Atahan, Ibtisam L.
    [J]. CANCER INVESTIGATION, 2007, 25 (05) : 315 - 321
  • [3] Pretreatment body mass index as an independent prognostic factor in patients with locoregionally advanced nasopharyngeal carcinoma treated with chemoradiotherapy: Findings from a randomised trial
    Huang, Pei-Yu
    Wang, Cheng-Tao
    Cao, Ka-Jia
    Guo, Xiang
    Guo, Ling
    Mo, Hao-Yuan
    Wen, Bi-Xiu
    Wu, Yi-Shan
    Mai, Hai-Qiang
    Hong, Ming-Huang
    [J]. EUROPEAN JOURNAL OF CANCER, 2013, 49 (08) : 1923 - 1931
  • [4] Serum C-reactive protein predicts poor prognosis in patients with locoregionally advanced nasopharyngeal carcinoma treated with chemoradiotherapy
    Zeng, Y. C.
    Wu, R.
    Xiao, Y. P.
    Chi, F.
    Xue, M.
    Zhang, Z. Y.
    Xing, R.
    Zhong, W. Z.
    Wang, S. L.
    Tian, X.
    Chen, W.
    Chen, J. J.
    Wu, L. N.
    [J]. CURRENT ONCOLOGY, 2015, 22 (01) : 20 - 24
  • [5] Prognostic Nomogram For Locoregionally Advanced Nasopharyngeal Carcinoma
    Jiang, Yanming
    Qu, Song
    Pan, Xinbin
    Huang, Shiting
    Zhu, Xiaodong
    [J]. SCIENTIFIC REPORTS, 2020, 10 (01)
  • [6] Prognostic Nomogram For Locoregionally Advanced Nasopharyngeal Carcinoma
    Yanming Jiang
    Song Qu
    Xinbin Pan
    Shiting Huang
    Xiaodong Zhu
    [J]. Scientific Reports, 10
  • [7] Prognostic implications of post-therapy 18F-FDG PET in patients with locoregionally advanced nasopharyngeal carcinoma treated with chemoradiotherapy
    Chan, Sheng-Chieh
    Kuo, Wen-Han
    Wang, Hung-Ming
    Chang, Joseph Tung-Chieh
    Lin, Chien-Yu
    Ng, Shu-Hang
    Hsu, Cheng-Lung
    Chang, Kai-Ping
    Liao, Chun-Ta
    Lin, Yu-Jr
    Yen, Tzu-Chen
    [J]. ANNALS OF NUCLEAR MEDICINE, 2013, 27 (08) : 710 - 719
  • [8] Prognostic implications of post-therapy 18F-FDG PET in patients with locoregionally advanced nasopharyngeal carcinoma treated with chemoradiotherapy
    Sheng-Chieh Chan
    Wen-Han Kuo
    Hung-Ming Wang
    Joseph Tung-Chieh Chang
    Chien-Yu Lin
    Shu-Hang Ng
    Cheng-Lung Hsu
    Kai-Ping Chang
    Chun-Ta Liao
    Yu-Jr Lin
    Tzu-Chen Yen
    [J]. Annals of Nuclear Medicine, 2013, 27 : 710 - 719
  • [9] An Individualized Prognostic Model in Patients with Locoregionally Advanced Nasopharyngeal Carcinoma Based on Serum Metabolomic Profiling
    Zhou, Jiayu
    Deng, Yishu
    Huang, Yingying
    Wang, Zhiyi
    Zhan, Zejiang
    Cao, Xun
    Cai, Zhuochen
    Deng, Ying
    Zhang, Lulu
    Huang, Haoyang
    Li, Chaofeng
    Lv, Xing
    [J]. LIFE-BASEL, 2023, 13 (05):
  • [10] Prognostic impact of pretreatment serum superoxide dismutase activity in patients with locoregionally advanced nasopharyngeal carcinoma
    Qiu, Wenze
    Jiang, Jiali
    Zhan, Zejiang
    Huang, Laiji
    Deng, Jin
    Ye, Jiacai
    Li, Guo
    Liao, Kai
    Zhang, Huanhuan
    Ding, Yan
    Yuan, Yawei
    Zheng, Ronghui
    [J]. INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2022, 37 (01): : 21 - 30
12345